Megan Laudenbach

Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse

Michael D. Raleigh, Samantha J. Peterson, Megan Laudenbach et al. · PLoS ONE · 2017 · 85 citations · Full text

Medicine, Immunology, Pharmacology +17

Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins

Federico Baruffaldi, April M. Huseby Kelcher, Megan Laudenbach et al. · Molecular Pharmaceutics · 2018 · 57 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in Rats

Michael D. Raleigh, Megan Laudenbach, Federico Baruffaldi et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 54 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Effect of Currently Approved Carriers and Adjuvants on the Pre-Clinical Efficacy of a Conjugate Vaccine against Oxycodone in Mice and Rats

Marco Pravetoni, Jeffrey S. Vervacke, Mark D. Distefano et al. · PLoS ONE · 2014 · 52 citations · Full text

Medicine, Immunology, Pharmacology +17

The Frequency of Naive and Early-Activated Hapten-Specific B Cell Subsets Dictates the Efficacy of a Therapeutic Vaccine against Prescription Opioid Abuse

Megan Laudenbach, Federico Baruffaldi, Jeffrey S. Vervacke et al. · The Journal of Immunology · 2015 · 39 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +16